Mutual Fund Research

DSP Healthcare Fund-Reg(G)

As on Apr-19-2024 change fund
31.94  up-0.13 (-0.40%)

fund objective

The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2019-20202020-20212021-20222022-20232023-2024
NAV in Rs (as on 31-Mar-2024)10.8119.1621.8820.9132.76
Net Assets(Rs Crores) (as on 31-Mar-2024) 281.24 1109.58 1291.46 1202.10 2352.32
Scheme Returns(%)(Absolute)3.3179.3413.12-4.6056.86
B'mark Returns(%)(Absolute)NANANANANA
Category Rank3/7526/7544/7561/7620/90
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2023-202414.709.6012.5510.74
2022-2023-11.909.134.21-4.59
2021-202213.207.501.95-7.96
2020-202126.1728.859.65-0.61
2019-2020-6.021.0710.07-0.76
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...14.04 
Ipca Laboratories Ltd.8.44 
Suven Pharmaceuticals Ltd.8.33 
Cipla Ltd.8.17 
Lupin Ltd.7.51 
Alembic Pharmaceuticals Ltd.5.93 
Apollo Hospitals Enterprise Ltd.5.03 
Globus Medical Inc4.22 
Concord Biotech Ltd.4.04 
Zydus Lifesciences Ltd.3.54 

Category

Sector Funds

Launch Date

30-Nov-18

Scheme Benchmark

S&P BSE HEALTH CARE - TRI

AUM ( in Cr.)

2,352.32

portfolio price to book value

6.64

investing style?

Large Growth

fund manager?

Chirag Dagli,Jay Kothari

inception date (regular plan)

30-Nov-18

expense ratio (regular plan) %

1.98

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs72.51
Hospital & Healthcare Services12.53
Insurance1.73

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes and benchmark
scheme name investment style inception date AUM in Cr. 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
DSP Healthcare Fund-Reg(G)Large-Growth 30-Nov-20182,352.3248.1115.9825.25NA24.05
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19992,626.3449.4617.5422.6615.4116.03
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20183,772.3255.7717.5123.96NA21.04
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-2015878.7049.0815.8721.71NA11.40
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20047,125.2847.8415.6022.1916.8620.65
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20182,235.1544.9414.6723.08NA21.11
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019699.5551.7814.04NANA21.78
UTI Healthcare Fund-Reg(G)Large-Growth 01-Aug-2005947.2646.3913.8720.5013.6217.93
LIC MF Healthcare Fund-Reg(G)Large-Growth 28-Feb-201961.6942.2110.7518.40NA18.15
ITI Pharma & Healthcare Fund-Reg(G)Large-Growth 08-Nov-2021160.3943.70NANANA12.49
HDFC Pharma and Healthcare Fund-Reg(G)Large-Growth 04-Oct-2023800.65NANANANA22.78
WOC Pharma and Healthcare Fund-Reg(G)Large-Growth 06-Feb-2024108.61NANANANA-1.13
Kotak Healthcare Fund-Reg(G)Large-Growth 11-Dec-2023284.18NANANANA10.38
Quant Healthcare Fund-Reg(G)Large-Growth 17-Jul-2023264.51NANANANA34.66
Attention InvestorsKYC
Contact Us

Mobile No : +91 99674 32226
Tel : 22702326
Email id : assist@reliabullwealth.com

OUR OFFICE

ReliaBull Financial Services Private Limited,
No 4-D, 4th Floor, Victoria Plaza,
SV Road, Above Kora Showroom,
Santacruz West,
Mumbai – 400054

Subscribe

For all the Latest Market News, Investment Ideas.

Follow us

AMFI Registration No:88227

A Reliabull Financial Services Venture

Designed & Developed by  Accord Fintech Pvt. Ltd.